Display options
Share it on

Evid Based Complement Alternat Med. 2015;2015:384267. doi: 10.1155/2015/384267. Epub 2015 Jun 09.

In Vitro Antileukemic Activity of Xanthosoma sagittifolium (Taioba) Leaf Extract.

Evidence-based complementary and alternative medicine : eCAM

Marina L C Caxito, Rachell R Correia, Anne Caroline C Gomes, Graça Justo, Marsen G P Coelho, Cássia M Sakuragui, Ricardo M Kuster, Katia C C Sabino

Affiliations

  1. Departamento de Bioquímica, IBRAG, Centro Biomédico, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro (UERJ), Avenida Professor Manoel de Abreu 44, PAPC, 4° Andar, 20550-170 Rio de Janeiro, RJ, Brazil ; Núcleo de Pesquisas de Produtos Naturais, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  2. Departamento de Bioquímica, IBRAG, Centro Biomédico, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro (UERJ), Avenida Professor Manoel de Abreu 44, PAPC, 4° Andar, 20550-170 Rio de Janeiro, RJ, Brazil.
  3. Núcleo de Pesquisas de Produtos Naturais, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
  4. Instituto de Biologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.

PMID: 26180533 PMCID: PMC4477105 DOI: 10.1155/2015/384267

Abstract

Xanthosoma sagittifolium Schott is a herb of the Araceae family, popularly known as taioba, which is consumed as food in some regions of Brazil, Africa, and Asia. This species has already been evaluated for the antifungal activities. However, based on its potential antitumor activity, the present study further aimed to examine the antitumor, as well as chelation, activity of X. sagittifolium leaf extract. Results showed that hydroethanolic extract of X. sagittifolium leaves (HEXs-L) exhibits cytotoxic effects against the immortalized line of human T-lymphocytic (Jurkat) and myelogenous (K562) leukemia cells, but not nontumor RAW 264.7 macrophages or NIH/3T3 fibroblasts. HEXs-L inhibited 50.3% of Jurkat cell proliferation, reducing by 20% cells in G2/M phase, but increasing cells in sub-G1 phase, thereby inducing apoptosis by 54%. In addition, HEXs-L inhibited NO production by 59%, as determined by Griess reaction, and chelated 93.8% of free Fe(II), as demonstrated by ferrozine assay. Phytochemical studies were carried out by ESI-MS, identifying apigenin di-C-glycosides as major compounds. Overall, this work revealed that leaf extract of Xanthosoma sagittifolium presented chelating activity and in vitro antitumor activity, arresting cell cycle and inducing apoptosis of leukemia cells, thus providing evidence that taioba leaves may have practical application in cancer therapy.

References

  1. Exp Hematol. 2013 Sep;41(9):799-807.e4 - PubMed
  2. Eur J Med Chem. 2015 Mar 6;92:866-75 - PubMed
  3. Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2435-42 - PubMed
  4. Biochem Pharmacol. 2001 Dec 1;62(11):1439-47 - PubMed
  5. J Ethnopharmacol. 2004 Jun;92(2-3):291-5 - PubMed
  6. Clin Cancer Res. 2006 Dec 1;12(23):6876-83 - PubMed
  7. Food Chem Toxicol. 2009 Feb;47(2):283-8 - PubMed
  8. J Ethnopharmacol. 2004 Dec;95(2-3):183-9 - PubMed
  9. J Ethnopharmacol. 2005 Jan 15;96(3):563-8 - PubMed
  10. Oncol Rep. 2011 Jan;25(1):215-21 - PubMed
  11. J Mol Med (Berl). 2009 Oct;87(10):1023-7 - PubMed
  12. Exp Hematol. 2014 Dec;42(12):1022-30.e1 - PubMed
  13. Int J Cancer. 2007 Feb 1;120(3):451-8 - PubMed
  14. Pharm Biol. 2012 Jul;50(7):930-2 - PubMed
  15. Phytomedicine. 2009 Jun;16(6-7):609-16 - PubMed
  16. Ann Intern Med. 1994 Mar 15;120(6):490-9 - PubMed
  17. Nutrition. 2013 Jan;29(1):15-21 - PubMed
  18. Molecules. 2008 Sep 04;13(9):2114-25 - PubMed
  19. Eur J Pharmacol. 2008 Jul 28;589(1-3):1-7 - PubMed
  20. Nutr Rev. 1997 Jan;55(1 Pt 2):S44-9; discussion S49-52 - PubMed
  21. Crit Rev Oncol Hematol. 2002 Jun;42(3):267-81 - PubMed
  22. Clin Cancer Res. 2013 Oct 15;19(20):5557-63 - PubMed
  23. J Intern Med. 2009 Apr;265(4):421-38 - PubMed
  24. Clin Cancer Res. 2003 Jan;9(1):402-14 - PubMed
  25. Mol Neurobiol. 2012 Dec;46(3):682-92 - PubMed
  26. Blood. 1995 Sep 15;86(6):2268-80 - PubMed
  27. Dig Dis. 2010;28(4-5):579-84 - PubMed
  28. J Ethnopharmacol. 2011 May 17;135(2):492-500 - PubMed
  29. J Agric Food Chem. 2003 Oct 22;51(22):6423-8 - PubMed
  30. Food Chem. 2012 Oct 15;134(4):1885-91 - PubMed
  31. J Ethnopharmacol. 2005 May 13;99(1):37-41 - PubMed
  32. Arterioscler Thromb. 1994 Feb;14(2):299-304 - PubMed
  33. J Immunol Methods. 1983 Dec 16;65(1-2):55-63 - PubMed
  34. Br J Haematol. 1995 Jan;89(1):181-7 - PubMed
  35. Anal Biochem. 1982 Oct;126(1):131-8 - PubMed
  36. Nutr Cancer. 2014;66(4):599-612 - PubMed
  37. Cancer Lett. 1998 Mar 13;125(1-2):199-207 - PubMed
  38. Exp Hematol. 2013 Jun;41(6):539-46 - PubMed
  39. ScientificWorldJournal. 2013 Dec 29;2013:162750 - PubMed
  40. Phytochemistry. 1996 Mar;41(4):1191-5 - PubMed
  41. Evid Based Complement Alternat Med. 2015;2015:756482 - PubMed
  42. Molecules. 2011 Sep 29;16(10):8305-18 - PubMed
  43. Tumour Biol. 2014 Aug;35(8):7719-26 - PubMed
  44. Nat Rev Drug Discov. 2011 Mar;10(3):221-37 - PubMed
  45. Curr Med Chem. 2003 Jun;10(12):983-95 - PubMed
  46. Chin Med J (Engl). 1989 Dec;102(12):902-5 - PubMed
  47. Anticancer Agents Med Chem. 2013 Dec;13(10):1601-13 - PubMed
  48. Cell. 2007 Feb 23;128(4):669-81 - PubMed
  49. J Ethnopharmacol. 2007 Dec 3;114(3):406-11 - PubMed
  50. J Ethnopharmacol. 2012 Sep 28;143(2):383-96 - PubMed
  51. Nature. 2008 Jul 24;454(7203):436-44 - PubMed
  52. Cancer Lett. 2000 Nov 10;160(1):107-13 - PubMed
  53. J Food Sci. 2013 Dec;78(12):H1929-34 - PubMed
  54. Biochem Pharmacol. 1998 Aug 15;56(4):431-7 - PubMed
  55. Front Biosci. 2008 Jan 01;13:2191-202 - PubMed
  56. Food Chem Toxicol. 2009 Aug;47(8):1848-51 - PubMed

Publication Types